MedPath
HSA Approval

POLARINE SYRUP

SIN03182P

POLARINE SYRUP

POLARINE SYRUP

May 31, 1989

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Therapeutic

Pharmacy Only

Formulation Information

SYRUP

ORAL

Medical Information

R06AB52

dexchlorpheniramine, combinations

Manufacturer Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL SDN BHD

Active Ingredients

PSEUDOEPHEDRINE HCl

30 mg/5 ml

Pseudoephedrine

DEXCHLORPHENIRAMINE MALEATE

2 mg/5 ml

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

POLARINE SYRUP - HSA Approval | MedPath